Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 12 studies | 36% ± 13% | |
endothelial cell of lymphatic vessel | 10 studies | 27% ± 12% | |
endothelial cell | 5 studies | 22% ± 3% | |
retinal rod cell | 5 studies | 30% ± 6% | |
oligodendrocyte precursor cell | 5 studies | 24% ± 6% | |
epithelial cell | 4 studies | 23% ± 2% | |
astrocyte | 4 studies | 24% ± 6% | |
glutamatergic neuron | 4 studies | 39% ± 11% | |
goblet cell | 4 studies | 25% ± 9% | |
ciliated cell | 3 studies | 26% ± 1% | |
GABAergic neuron | 3 studies | 37% ± 6% | |
neuron | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1610.98 | 2642 / 2642 | 100% | 32.45 | 705 / 705 |
esophagus | 100% | 948.54 | 1445 / 1445 | 100% | 23.46 | 183 / 183 |
stomach | 100% | 616.17 | 358 / 359 | 100% | 19.96 | 286 / 286 |
lung | 100% | 1008.47 | 577 / 578 | 100% | 19.92 | 1153 / 1155 |
prostate | 100% | 928.84 | 245 / 245 | 100% | 30.18 | 500 / 502 |
intestine | 100% | 913.65 | 966 / 966 | 99% | 22.34 | 524 / 527 |
ovary | 100% | 755.12 | 180 / 180 | 99% | 13.20 | 427 / 430 |
bladder | 100% | 982.38 | 21 / 21 | 99% | 21.16 | 500 / 504 |
breast | 100% | 914.33 | 459 / 459 | 99% | 17.81 | 1103 / 1118 |
uterus | 100% | 888.18 | 170 / 170 | 98% | 20.60 | 451 / 459 |
thymus | 100% | 978.79 | 652 / 653 | 98% | 17.10 | 591 / 605 |
skin | 100% | 1140.94 | 1808 / 1809 | 96% | 20.54 | 455 / 472 |
kidney | 100% | 745.30 | 89 / 89 | 96% | 15.75 | 866 / 901 |
liver | 100% | 728.04 | 226 / 226 | 96% | 11.25 | 390 / 406 |
pancreas | 96% | 379.20 | 314 / 328 | 99% | 15.59 | 176 / 178 |
adrenal gland | 100% | 768.43 | 258 / 258 | 93% | 12.77 | 213 / 230 |
muscle | 100% | 1000.40 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 852.87 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.31 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.73 | 1 / 1 |
adipose | 100% | 880.88 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 799.09 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 436.81 | 817 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 20.21 | 75 / 80 |
peripheral blood | 91% | 750.02 | 843 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 16.05 | 26 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1905668 | Biological process | positive regulation of protein localization to endosome |
GO_1902817 | Biological process | negative regulation of protein localization to microtubule |
GO_1902950 | Biological process | regulation of dendritic spine maintenance |
GO_1902473 | Biological process | regulation of protein localization to synapse |
GO_0002084 | Biological process | protein depalmitoylation |
GO_0099175 | Biological process | regulation of postsynapse organization |
GO_0010008 | Cellular component | endosome membrane |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0008474 | Molecular function | palmitoyl-(protein) hydrolase activity |
Gene name | ABHD17B |
Protein name | Alpha/beta hydrolase domain-containing protein 17B (Abhydrolase domain-containing protein 17B) (EC 3.1.2.22) |
Synonyms | FAM108B1 CGI-67 C9orf77 |
Description | FUNCTION: Hydrolyzes fatty acids from S-acylated cysteine residues in proteins . Has depalmitoylating activity towards DLG4/PSD95 . Has depalmitoylating activity towards GAP43 (By similarity). Has depalmitoylating activity towards MAP6 (By similarity). Has depalmitoylating activity towards NRAS . . |
Accessions | ENST00000377041.6 [Q5VST6-2] ENST00000333421.7 [Q5VST6-1] Q5VST6 |